tykhr
sign in
free sign up
Xeris Pharmaceuticals Inc
Biotechnology
Healthcare
XERS
149 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
4.03
52 week high
5.87
high
4.39
52 week low
2.06
low
3.82
growth
91.59 %
previous Close
4.13
P/E ratio
market cap
522 M
div yield
0
usd
Sep 2024
qoq
revenue
54.27 M
12.91 %
net incoming
-15.74 M
-4.89 %
eps
0.00 %
-10.00 %
eps surprise
-22.22 %
net profit margin
-29.00 %
2.00 %
operating incoming
-12.89 M
-57.48 %
net change in cash
5.75 M
213.08 %
cash on hand
59.23 M
2.83 %
cost of revenue
13.59 M
29.46 %
top